Briefly, in neoadjuvant settings, preoperative EsCu@NPs reduce tumor burden, decrease minimal residual disease, curb postsurgical recurrence and spontaneous lung metastasis, translating into prolonged survival
Redox-sensitive signaling in inflammatory T cells and in autoimmune disease
Heres what to know: Hunger may still appear, but fullness comes sooner Emotional or habit-based hunger can linger at first Cravings often ease before hunger fully quiets Appetite suppression strengthens with dose adjustments Many people notice they can eat less, even if hunger cues are still present
analyzed patients initially treated with GLP-1 RAs or SGLT2i, subsequently adding the second agent to evaluate the effects of combination therapy compared to monotherapy and differencing across groups ( Table 3 )
Conclusion Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide, imposing substantial social and economic burdens